Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis

Read full text
Authors: Gautier Bréville, Ayman Rezk, Samuel Weissman, Diego A. Espinoza, Simon Thébault, Luana D. Yamashita, Yeseul Kim, Mihir Kakara, Liljana Nedelkoska, Nicole Doyon-Reale, Celine Delucinge-Vivier, Leah Zuroff
+5 more Hanane Touil, Paul M. Stemmer, Joyce A. Benjamins, Robert P. Lisak, Amit Bar‐Or
Cited by: 1
References: 50

Abstract

BACKGROUND AND OBJECTIVES: Compartmentalized CNS inflammation involving B cells is implicated in gray matter injury and disease progression in multiple sclerosis (MS). Products secreted by B cells of patients with MS can kill oligodendrocytes and neurons, a cytotoxicity conferred by their exosome-enriched extracellular vesicle (Ex En) fraction. METHODS: To explore the potential molecular mediators of this cytotoxicity, we profiled proteomic and transcriptomic cargo of Ex En isolated from B cells of patients with treatment-naive MS and matched healthy controls. RESULTS: MS B-cell-derived Ex En appeared enriched in cell-death-associated proteins (including fibrinogen, complement C9, APP, and SPARC) and deficient in cell-survival-associated proteins (such as galectin-3). Abnormal enrichment for cell-death proteins was supported by gene set enrichment analysis. Protein pathway analysis revealed densely connected prodeath modules in the MS B-cell-derived Ex En, contrasting with homeostatic signatures in controls. Transcriptomic analysis further revealed that Ex En of MS B cells appeared to carry reduced levels of miRNAs (miR-182, miR-212, and miR-1270) known to inhibit apoptosis. DISCUSSION: Our findings indicate that B-cell-derived Ex En of patients with MS, previously shown to impair neuronal and glial survival, harbor an abnormal cytotoxic molecular profile that may contribute to CNS-compartmentalized injury and progressive MS biology.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Polyomavirus and related diseases CAR-T cell therapy research

Publication details

Journal / source
Neurology Neuroimmunology & Neuroinflammation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
13
Issue
4
Pages
e200590–e200590
Publication date
9 June 2026
Language
EN